Is sinopharm vaccine accepted in canada. 5 million yuan ($105. 国药集团党委2025年第一轮巡视完成反馈 白忠泉董事长与山西省卢东亮省长会谈 国药集团精彩亮相第四届中国（澳门）国际高品质消费博览会暨横琴世界湾区论坛 赵炳祥总经理到吉林靖宇调研定点帮扶工作 国药集团党委召开理论学习中心组2025年第5次集体学习（扩大）会 国药集团党委召开扩大会议 Sinopharm’s expanding role in BRI countries Sinopharm’s chairman holds fruitful meeting with CEO of RX Sinopharm general manager speaks at Shanghai pharmaceutical event Sinopharm expands business collaborations at seventh CIIE More >> Sinopharm News Sinopharm is a globally leading company in the healthcare sector in terms of scale, performance and comprehensive strength. It has led or participated in the formulation of more than 3,500 national technical standards, obtained more than 3,490 patents and received over 5,000 drug production approvals. 23董 事 长：白忠泉 董 事：赵炳祥、赵玉坤、童国华、柴艳丽、张雷、高国华、王豹. CNMC has 15 wholly-owned or partially-owned subsidiaries and three joint ventures. Sinopharm Group Co Ltd (Sinopharm Holding) is in charge of Sinopharm’s medical & pharmaceutical commerce sector. Feb 24, 2023 · Over the years, Sinopharm has won more than 70 awards, including the State Scientific and Technological Progress Award. 中国医药集团有限公司（简称“国药集团”）是由国务院国资委直接管理的以生命健康为主业的中央企业。集团规模、效益和综合实力居于全球同行业领先地位，拥有科技研发、工业制造、物流分销、零售连锁、医疗健康、工程技术、专业会展、国际经营、金融投资等大健康全产业链。 国药集团 24中国医药工业研究总院有限公司所属子公司 上海益诺思生物技术股份有限公司 上海现代药物制剂工程研究中心有限公司 Jan 8, 2025 · A delegation from the Africa Centres for Disease Control and Prevention (Africa CDC) visited Beijing Institute of Biological Products Co Ltd, a subsidiary of China National Biotec Group Company Limited (CNBG) under China National Pharmaceutical Group Co Ltd (Sinopharm), on Dec 17. It has over 3000 employees in total. 23董 事 长：白忠泉 董 事：赵炳祥、赵玉坤、童国华、柴艳丽、张雷、高国华、王豹 国药集团党委2025年第一轮巡视完成反馈 白忠泉董事长与山西省卢东亮省长会谈 国药集团精彩亮相第四届中国（澳门）国际高品质消费博览会暨横琴世界湾区论坛 赵炳祥总经理到吉林靖宇调研定点帮扶工作 国药集团党委召开理论学习中心组2025年第5次集体学习（扩大）会 国药集团党委召开扩大会议 Sinopharm’s expanding role in BRI countries Sinopharm’s chairman holds fruitful meeting with CEO of RX Sinopharm general manager speaks at Shanghai pharmaceutical event Sinopharm expands business collaborations at seventh CIIE More >> Sinopharm News Sinopharm is a globally leading company in the healthcare sector in terms of scale, performance and comprehensive strength. Initiated by Sinopharm, it went public on the Shanghai Stock Exchange in November 2002 with a registered capital of 754. 84 million) (stock code: 600511). mlsr bblc wt8i c6mr kicpj c2clg ewfpo0 jn9u tn f5i